Insights

Innovative Agriculture Solutions Enko's focus on designing safe and sustainable crop protection solutions using advanced drug discovery approaches from pharma indicates strong innovation potential. This positions them as a valuable partner for agricultural companies seeking cutting-edge, environmentally friendly products.

Strategic Partnerships Enko's collaborations with industry leaders like Syngenta and Nufarm, as well as recent board additions, demonstrate a commitment to expanding its reach and credibility. These partnerships present opportunities to introduce complementary products or joint ventures within the crop protection market.

Funding & Growth With recent investments exceeding 140 million dollars and substantial venture backing, Enko is scaling rapidly, especially in areas like AI-driven herbicides and pesticides. This growth trajectory offers opportunities to align with their expanding R&D pipeline and co-develop innovative solutions.

Technology Integration Utilizing advanced technology stacks including AI, cloud computing, and machine learning provides a platform for developing novel crop solutions. Engaging with Enko could enable access to innovative digital tools to enhance product efficacy and sustainability claims.

Market Expansion Potential With a focus on addressing major crop threats such as pest resistance and fungal diseases, Enko is positioned to disrupt traditional crop protection markets. This creates opportunities to introduce products or services that support their pipeline and meet the evolving needs of modern agriculture.

Enko® Tech Stack

Enko® uses 8 technology products and services including Amazon Web Services, Cloudflare, PostgreSQL, and more. Explore Enko®'s tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Cloudflare
    Content Management System
  • PostgreSQL
    Database
  • NetSuite
    E-commerce
  • Plotly
    Javascript Graphics
  • LinkedIn
    Online Community Software
  • Python
    Programming Languages
  • JDA
    Supply Chain Management

Media & News

Enko®'s Email Address Formats

Enko® uses at least 2 format(s):
Enko® Email FormatsExamplePercentage
First.Last@enkochem.comJohn.Doe@enkochem.com
98%
Fir.Last@enkochem.comJoh.Doe@enkochem.com
2%
First_Last@enko.agJohn_Doe@enko.ag
100%

Frequently Asked Questions

Where is Enko®'s headquarters located?

Minus sign iconPlus sign icon
Enko®'s main headquarters is located at 62 Maritime Drive Mystic, Connecticut 06355 United States. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is Enko®'s stock symbol?

Minus sign iconPlus sign icon
Enko® is a publicly traded company; the company's stock symbol is CNKS.L.

What is Enko®'s official website and social media links?

Minus sign iconPlus sign icon
Enko®'s official website is enko.ag and has social profiles on LinkedIn.

What is Enko®'s SIC code NAICS code?

Minus sign iconPlus sign icon
Enko®'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Enko® have currently?

Minus sign iconPlus sign icon
As of March 2026, Enko® has approximately 56 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: A. K.Vice President Finance: S. P. S.Company Owner: A. P.. Explore Enko®'s employee directory with LeadIQ.

What industry does Enko® belong to?

Minus sign iconPlus sign icon
Enko® operates in the Biotechnology Research industry.

What technology does Enko® use?

Minus sign iconPlus sign icon
Enko®'s tech stack includes Amazon Web ServicesCloudflarePostgreSQLNetSuitePlotlyLinkedInPythonJDA.

What is Enko®'s email format?

Minus sign iconPlus sign icon
Enko®'s email format typically follows the pattern of First.Last@enkochem.com. Find more Enko® email formats with LeadIQ.

When was Enko® founded?

Minus sign iconPlus sign icon
Enko® was founded in 2017.

Enko®

Biotechnology ResearchConnecticut, United States51-200 Employees

Enko® designs safe and sustainable solutions to farmers’ biggest crop threats, from pest resistance to new diseases. By applying the latest drug discovery and development approaches from pharma to plants, Enko is bringing an innovation model to agriculture and meeting farmers’ evolving needs. Founded in 2017 and led by a team of proven scientists, entrepreneurs and agriculture industry veterans, Enko is backed by investors including the Bill & Melinda Gates Foundation, Anterra Capital, Finistere Ventures, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food, and Rabo Food & Agri Innovation Fund.

Section iconCompany Overview

Headquarters
62 Maritime Drive Mystic, Connecticut 06355 United States
Website
enko.ag
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CNKS.L
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $10M$25M

    Enko®'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Enko®'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.